Press Releases October 1, 2026 04:05 PM

Robinhood Markets, Inc. to Announce Third Quarter 2026 Results on October 27, 2026

Robinhood Markets Announces Q3 2026 Earnings Release Date and Shareholder Q&A Platform Launch

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
HOOD

Robinhood Markets, Inc. announced it will publish its third quarter 2026 financial results on October 27, 2026, followed by an earnings call with key executives. The company has also introduced a new Q&A platform for shareholders to submit and upvote questions ahead of the call. The webcast and related materials will be accessible via the company's investor relations website and official social media channels.

Robinhood Markets, Inc. to Announce Third Quarter 2026 Results on October 27, 2026
HOOD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Robinhood will release Q3 2026 earnings on October 27, 2026, after market close.
  • A shareholder Q&A platform will allow investors to submit and upvote questions to management before the earnings call.
  • The earnings call will be live streamed and later made available as a replay and transcript online.

MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its third quarter 2026 financial results on Tuesday, October 27, 2026, after market close. Robinhood will host a video call with Chairman & Chief Executive Officer Vlad Tenev and Chief Financial Officer Shiv Verma to discuss its results at 2:00 PM PT / 5:00 PM ET on the same day. The video call and supporting materials will be available at investors.robinhood.com. The event will also be live streamed to YouTube and X.com via Robinhood’s official channels, @RobinhoodApp, and within the Robinhood mobile app. Following the call, a replay and transcript will be available at investors.robinhood.com.

Ahead of the call, Robinhood shareholders can visit https://app.saytechnologies.com/robinhood-markets-2026-q3 to submit and upvote questions for management using the Q&A platform developed by Say by Robinhood. The Q&A platform will be open for question submission starting Tuesday, October 20, 2026, at 2:00 PM PT / 5:00 PM ET. Shareholders will be able to submit and upvote questions until Monday, October 26, 2026, at 2:00 PM PT / 5:00 PM ET. Management will address a selection of the most upvoted questions relating to Robinhood’s business and financial results on the earnings call. Shareholders can email [email protected] for any support inquiries.

About Robinhood

Robinhood Markets, Inc. (NASDAQ: HOOD) is a global leader in financial services offering retail brokerage, crypto, advisory, digital banking services, and private markets access to a new generation of investors. Additional information about Robinhood can be found at robinhood.com.

Robinhood uses the “Overview” tab of its Investor Relations website (accessible at investors.robinhood.com/overview) and its Newsroom (accessible at newsroom.aboutrobinhood.com), as means of disclosing information to the public in a broad, non-exclusionary manner for purposes of the U.S. Securities and Exchange Commission (SEC) Regulation Fair Disclosure (Reg. FD). Investors should routinely monitor those web pages, in addition to Robinhood’s press releases, SEC filings, and public conference calls and webcasts, as information posted on them could be deemed to be material information.

“Robinhood” and the Robinhood feather logo are registered trademarks of Robinhood Markets, Inc. All other names are trademarks and/or registered trademarks of their respective owners.

Contacts

Investor Relations: [email protected]

Press: [email protected]


Risks

  • Earnings might not meet investor expectations, which could negatively impact the stock price.
  • Uncertainty around the company's financial performance given the competitive fintech and brokerage sector.
  • Potential regulatory risks in the financial services and crypto sectors impacting Robinhood's operations.

More from Press Releases

Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A) Oct 2, 2026 Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 Oct 1, 2026 New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program Oct 1, 2026 FEMSA Schedules Conference Call to Discuss Third Quarter Financial Results Oct 1, 2026 Exodus Brings Stablecoins to Everyday Commerce, Starting With DIRECTV’s DGO Oct 1, 2026